Related peptides can be compared at the molecular level without establishing that they are equivalent medicines. This study examined two ACTH-derived structures after experimental ischemia. Primary report
Study snapshot
RNA sequencing assessed rat frontal cortex 24 hours after transient middle cerebral artery occlusion. Semax and ACTH(6–9)PGP produced overlapping changes involving immune and neural-signaling genes, with relatively few directly differing genes under the reported thresholds. Comparison with earlier observations indicated that the expression pattern depended on time after ischemia. Primary report
Our appraisal: the threshold defines the list
Differential-expression counts depend on effect-size and statistical thresholds. Two lists that overlap extensively are informative, but the count alone does not reveal the importance of each gene or the magnitude of every response. A short list of differences can still contain biologically important distinctions.
Absence from a significant-gene list is not proof of equal expression. Direct comparison, uncertainty, sample size, and assay sensitivity all matter. Formal equivalence would require an appropriately defined question rather than simply few significant differences.
Time is part of the intervention context. A single 24-hour snapshot cannot establish identical early signaling, duration of action, or later recovery. Nor can a tissue-level profile isolate whether expression changed within cells or because the sampled cell mixture changed.
This report is related to an existing experimental program, not independent clinical replication of Semax. Full review should map sample and publication lineage, analysis thresholds, batch handling, and validation experiments. Its contribution is a molecular comparison that may guide further testing, not a basis for substituting one peptide for another in people.
Frequently asked questions
Were the two peptides chemically identical?
No.
What tissue and time were emphasized?
Rat frontal cortex at 24 hours after transient ischemia.
Did expression responses overlap?
Yes.
Do few significant differences prove equivalence?
No.
Can thresholds change the number of listed genes?
Yes.
Was clinical interchangeability tested?
No.
What is the useful conclusion?
A time-specific molecular comparison that requires functional and translational validation.